View by Specialty

Trending

Potentially modifiable dementia risk factors
July 31, 2024
3 min read
Save

Eliminating these 14 risk factors may prevent nearly half of dementia cases

Practice Management News

SPONSORED CONTENT
Save
SPONSORED CONTENT
July 09, 2024
2 min read
Save

Men develop IgG4-related disease more than twice as often as women

Men develop IgG4-related disease more than twice as often as women

Men are more than twice as likely than women to develop IgG4-related disease, and demonstrate “striking” sex-dependent organ distribution and B-cell response, according to data published in The Lancet Rheumatology.

SPONSORED CONTENT
July 08, 2024
2 min read
Save

Disability insurance protects against financial demise

Disability insurance protects against financial demise

Like many sports, such as soccer and basketball, financial independence requires simultaneous offense and defense. One of the most important defensive plays a physician must make is buying disability insurance.

Trending

Potentially modifiable dementia risk factors
July 31, 2024
3 min read
Save

Eliminating these 14 risk factors may prevent nearly half of dementia cases

SPONSORED CONTENT
July 02, 2024
2 min read
Save

FDA reduces risk reporting for CAR T cells to ‘minimize the burden’ on providers

FDA reduces risk reporting for CAR T cells to ‘minimize the burden’ on providers

FDA has scaled back its Risk Evaluation and Mitigation Strategy reporting requirements for providers of chimeric antigen receptor T-cell therapies.

SPONSORED CONTENT
July 02, 2024
3 min read
Save

‘Ho-ho, ha-ha-ha!’ Try laughter yoga to improve well-being

‘Ho-ho, ha-ha-ha!’ Try laughter yoga to improve well-being

To combat the myriad of stressors in life, taking a break to plug into your inner joy opens the door to increased well-being.

SPONSORED CONTENT
July 01, 2024
5 min read
Save

Protect a physician’s most valuable asset with disability insurance

Protect a physician’s most valuable asset with disability insurance

Given the substantial investment to become a practicing physician, it should not be surprising that the most significant asset of most physicians is their ability to practice their profession.

SPONSORED CONTENT
June 27, 2024
2 min read
Save

Supreme Court blocks Sackler family immunity, dismantles Purdue Pharma bankruptcy plan

Supreme Court blocks Sackler family immunity, dismantles Purdue Pharma bankruptcy plan

The U.S. Supreme Court ruled 5-4 on Thursday that members of the Sackler family cannot be protected from future lawsuits for their roles in the opioid epidemic.

SPONSORED CONTENT
June 27, 2024
10 min listen
Save

Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of June 24, 2024

Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of June 24, 2024

In this edition, extensive psoriasis and IBD history predict difficult-to-treat psoriatic arthritis, targeted therapies demonstrate low risk for serious infection and more.

SPONSORED CONTENT
June 26, 2024
2 min read
Save

JAK, IL-6 inhibition most effective targeted therapies for VEXAS syndrome

JAK, IL-6 inhibition most effective targeted therapies for VEXAS syndrome

The most efficacious targeted therapies for VEXAS syndrome are Janus kinase inhibitors and interleukin-6 inhibitors, while IL-1 and TNF blockers are less effective, according to data published in the Annals of the Rheumatic Diseases.

SPONSORED CONTENT
June 26, 2024
2 min listen
Save

NSAIDs, Part 2: The Dawn of the Anti-Inflammatories

NSAIDs, Part 2: The Dawn of the Anti-Inflammatories

In this episode, we dive into the story of aspirin and the development of ibuprofen, ending with the experiments that showed the mechanism of how aspirin actually works.

SPONSORED CONTENT
June 25, 2024
2 min read
Save

Antibody boosts platelets, shows ‘rapid and sustained efficacy’ in immune thrombocytopenia

Antibody boosts platelets, shows ‘rapid and sustained efficacy’ in immune thrombocytopenia

Treatment with the novel antibody CM313 boosted platelet levels and demonstrated long-term durability among adults with immune thrombocytopenia, results from a phase 2 study showed.

View more